Should Patient-Reported Outcomes Be Mandatory for Toxicity Reporting in Cancer Clinical Trials?-Reference-Cited by-同舟云学术

Should Patient-Reported Outcomes Be Mandatory for Toxicity Reporting in Cancer Clinical Trials?

Published:2007-12-01 Issue:34 Volume:25 Page:5345-5347
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Bruner Deborah Watkins¹

Affiliation:

1. School of Nursing, University of Pennsylvania, Philadelphia, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.13.3330

Reference17 articles.

1. Is cancer treatment toxicity accurately reported?

2. The Need for and Characteristics of Randomized, Phase III Trials to Evaluate Symptom Management in Patients With Cancer

3. US Department of Health and Human Services: Guidance for industry: Patient-reported outcomes measures—Use in medical product development to support labeling claims , 2006. http://www.fda.gov/cder/guidance/5460dft.pdf

4. Long-Term Toxicity Monitoring via Electronic Patient-Reported Outcomes in Patients Receiving Chemotherapy

5. Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy Toxicities

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives;Patient Related Outcome Measures;2022-12

2. Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®);Tumori Journal;2022-06-08

3. Quality of Life in Older Patients with Cancer;Encyclopedia of Gerontology and Population Aging;2021

4. Quality of in Older Patients with Cancer;Encyclopedia of Gerontology and Population Aging;2021

5. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide;Annals of Oncology;2018-08